Seikagaku Corp represents values of innovation, commitment to research and development, and a philosophy centered around improving quality of life. With a focus on biomedical research and development, Seikagaku Corp aims to contribute to society by enhancing healthcare and addressing unmet medical needs. The company strives to provide reliable products that meet the highest quality standards, emphasizing integrity and professionalism in all its operations. Seikagaku Corp's dedication to scientific excellence, customer satisfaction, and social responsibility makes it a trusted and leading player in the field of biotechnology and pharmaceuticals.

Seikagaku Corp is primarily present in Japan.

Seikagaku Corp, a renowned company, has achieved several significant milestones. It has successfully developed and launched innovative products that have revolutionized the healthcare industry. The company's dedication to research and development has resulted in breakthrough discoveries and advancements in various therapeutic areas. Seikagaku Corp has also gained global recognition for its cutting-edge technology and has expanded its market presence internationally. With a strong commitment to improving human health, this company has continuously demonstrated exceptional growth and has established itself as a leader in the pharmaceutical sector. Seikagaku Corp's remarkable achievements continue to shape the future of healthcare.

Seikagaku Corp, a renowned Japanese company, has a rich history and background in the healthcare industry. Established in 1947, Seikagaku focuses on developing and manufacturing medical devices, as well as pharmaceuticals and biomaterials. With its commitment to innovation and scientific research, Seikagaku Corp has become a global leader in the fields of orthopedics, regenerative medicine, and dermatology. The company's cutting-edge products and technologies have garnered recognition for their effectiveness and safety. Through strategic partnerships and collaborations, Seikagaku Corp continues to contribute to the advancement of healthcare, improving the quality of life for individuals worldwide.

The main competitors of Seikagaku Corp in the market are Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, Astellas Pharma Inc., and Eisai Co., Ltd.

Seikagaku Corp is primarily active in the medical and healthcare industries.

The business model of Seikagaku Corp revolves around the development, manufacture, and sale of pharmaceutical products. As a leading Japanese biotechnology company, Seikagaku Corp focuses on research and development in the fields of osteoarthritis, inflammation, and orthopedics. The company's main products include pharmaceuticals, medical devices, and regenerative medicine products that aim to address unmet medical needs. Seikagaku Corp strives to contribute to society by improving the health and quality of life for patients worldwide through its innovative solutions and commitment to advancing medical science.

مُعامل القيمة السوقية إلى الأرباح لـ Seikagaku هو ٢٠٫٤١.

مُعامِل القيمة إلى المبيعات Seikagaku هو ١٫٢٣.

نقاط جودة AlleAktien لـ Seikagaku هي 2/10.

Seikagaku الإيرادات هي ٣٦٫٢١ مليارات JPY.

صافي الربح Seikagaku هو ٢٫١٩ مليارات JPY.

The Seikagaku Corporation is a leading biopharmaceutical company based in Tokyo, Japan. It has been dedicated to the development of innovative products and therapies for patients worldwide for over 60 years. The company focuses on three main business areas: Medical Devices, Pharmaceuticals, and Diagnostics. The Medical Devices division offers a wide range of products and services for orthopedic and traumatological applications, with a particular emphasis on hyaluronic acid products for the treatment of osteoarthritis. The Pharmaceuticals division focuses on research and development of novel therapeutics for inflammatory diseases and cancer, with a focus on wet age-related macular degeneration (AMD), rheumatoid arthritis, other autoimmune diseases, and various forms of cancer. The Diagnostics division specializes in products and services for clinical diagnostics and disease monitoring, particularly in areas where diagnostic markers are difficult to identify and quantify, such as cancer. Seikagaku is committed to continuously bringing innovative products and therapies to market through a strong research and development strategy, substantial investment in research and development, and strategic partnerships with other companies and research institutions. Overall, Seikagaku is a leading company in the field of biopharmaceuticals with a wide portfolio of products and services that consistently delivers new solutions for patient healthcare.

يوزع Seikagaku أرباحًا قدرها ١٨٫٠٠ JPY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Seikagaku في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـSeikagaku هو JP3414000004.

الرمز المُختصر لـ Seikagaku هو 4548.T.

خلال آخر 12 شهراً، دفعت Seikagaku توزيعات أرباح بقيمة ٢٨٫٠٠ JPY . وهذا يعادل عائد توزيعات أرباح يقارب ٣٫٤٢ %. ومن المتوقع أن تدفع Seikagaku خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٢٩٫١٢ JPY.

نسبة توزيعات الأرباح الحالية لـ Seikagaku هي ٣٫٤٢ %.

Seikagaku يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, أبريل, أكتوبر, أبريل.

Seikagaku دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٢٩٫١٢ JPY. وهذا يعادل عائد توزيعات أرباح قدره ٣٫٥٦ %.

Seikagaku يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٥ JPY من Seikagaku المُعلن عنها في ١‏/١٢‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/١٢‏/٢٠٢٤.

في العام 2023، وزعت Seikagaku ٢٦ JPY كأرباح أسهم.

يتم توزيع أرباح Seikagaku بالعملة JPY.